|
| |
| | | 67678 | | 24.08.2020 | | Mepha Pharma AG | | | | | | | 23.08.2025 | | | | | | 06.99. | | | | 06.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Deferasirox-Mepha 90 mg | Lactab | Coated tablets (Deferasirox 90 mg) | V03AC03 | CI | | 02 | Deferasirox-Mepha 180 mg | Lactab | Coated tablets (Deferasirox 180 mg) | V03AC03 | | | 03 | Deferasirox-Mepha 360 mg | Lactab | Coated tablets (Deferasirox 360 mg) | V03AC03 | | | 04 | Deferasirox-Mepha 900 mg | Lactab | Coated tablets (Deferasirox 900 mg) | V03AC03 | |
|
|
|
